Kane Biotech Inc. (CVE:KNE – Get Free Report)’s stock price rose 14.3% during trading on Thursday . The company traded as high as C$0.04 and last traded at C$0.04. Approximately 180,000 shares traded hands during trading, an increase of 97% from the average daily volume of 91,506 shares. The stock had previously closed at C$0.04.
Kane Biotech Stock Up 14.3%
The company’s fifty day simple moving average is C$0.04 and its 200-day simple moving average is C$0.05. The company has a debt-to-equity ratio of -331.42, a current ratio of 0.80 and a quick ratio of 0.39. The firm has a market capitalization of C$6.65 million, a PE ratio of -0.44 and a beta of 0.23.
Kane Biotech Company Profile
Kane Biotech Inc, a biotechnology company, engages in the research, development, and commercialization of technologies and products that prevent and remove microbial biofilms in Canada and internationally. The company develops its products using coactiv+ technology, an antimicrobial wound gel platform; and DispersinB technology, a naturally occurring enzyme that cleaves the bacterial surface polysaccharide poly-b-1, 6-N-acetylglucosamine for treating wounds and otic infections.
See Also
- Five stocks we like better than Kane Biotech
- How to Invest in the Best Canadian Stocks
- AMD to $300 Looks Easy—Here’s Why $500 Could Be Next
- How to Calculate Retirement Income: MarketBeat’s Calculator
- $5B+ in Buybacks: What DraftKings, AppLovin, and Altria Are Telling You
- Low PE Growth Stocks: Unlocking Investment Opportunities
- 4 High-Yield Real Estate Stocks to Buy as Investors Get Defensive
Receive News & Ratings for Kane Biotech Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Kane Biotech and related companies with MarketBeat.com's FREE daily email newsletter.
